NRIX vs PG · rev $54.5M vs P/E 25, rev $84.28B
Nurix Therapeutics Inc (NRIX) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
NRIX currently screens at market cap $1.77B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the NRIX and PG stock pages for the full models.
Not investment advice.